%0
Generic
%T
Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy
%A Hong, Yong Sang
%A Lee, Jeeyun
%A Kim, Kyu-pyo
%A Lee, Jae-Lyun
%A Park, Young Suk
%A Park, Joon Oh
%A Park, Se Hoon
%A Kim, Sun Young
%A Baek, Ji Yeon
%A Kim, Jee Hyun
%A Lee, Keun-Wook
%A Kim, Tae-You
%A Kim, Tae Won
%I Springer Science and Business Media LLC
%@ 0167-6997
%@ 1573-0646
%K Pharmacology (medical)
%K Pharmacology
%K Oncology
%D 2013
%C Springer Science and Business Media LLC
%U http://slubdd.de/katalog?TN_libero_mab2